Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Teva
Baxter
Colorcon
Cipla
Covington
McKesson
AstraZeneca
Healthtrust

Generated: November 14, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 065197

« Back to Dashboard

NDA 065197 describes CEFOTAXIME SODIUM, which is a drug marketed by Aurobindo Pharma, Aurobindo Pharma Ltd, Cephazone Pharma, Hospira Inc, Lupin, and Wockhardt, and is included in nine NDAs. It is available from three suppliers. Additional details are available on the CEFOTAXIME SODIUM profile page.

The generic ingredient in CEFOTAXIME SODIUM is cefotaxime sodium. There are fourteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the cefotaxime sodium profile page.
Summary for 065197
Tradename:CEFOTAXIME SODIUM
Applicant:Wockhardt
Ingredient:cefotaxime sodium
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 065197
Ingredient-typeCephalosporins
Medical Subject Heading (MeSH) Categories for 065197
Suppliers and Packaging for NDA: 065197
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CEFOTAXIME cefotaxime sodium INJECTABLE;INJECTION 065197 ANDA WOCKHARDT LIMITED 55648-947 55648-947-02 10 CARTON in 1 CARTON (55648-947-02) > 1 VIAL, SINGLE-DOSE in 1 CARTON (55648-947-01) > 10 mL in 1 VIAL, SINGLE-DOSE
CEFOTAXIME cefotaxime sodium INJECTABLE;INJECTION 065197 ANDA WOCKHARDT LIMITED 55648-948 55648-948-02 10 CARTON in 1 CARTON (55648-948-02) > 1 VIAL, SINGLE-DOSE in 1 CARTON (55648-948-01) > 20 mL in 1 VIAL, SINGLE-DOSE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 1GM BASE/VIAL
Approval Date:Aug 29, 2006TE:APRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 500MG BASE/VIAL
Approval Date:Jun 20, 2008TE:APRLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 2GM BASE/VIAL
Approval Date:Jun 20, 2008TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Daiichi Sankyo
US Army
UBS
US Department of Justice
Dow
Cantor Fitzgerald
McKinsey
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.